Pediatric Drugs and Vaccines Market Analysis | 2021-2026

Market Insights

The Pediatric Drugs and Vaccines Market is estimated to grow from USD 92.8 billion in 2020 to USD 150.8 billion by 2026 at a healthy CAGR of 8.6% during the forecast period.

Wish to get a free sample? Register Here

What are pediatric drugs?

Pediatric drugs and vaccines are those given to children to guard them from harmful diseases which may be non-infectious or infectious. Sometimes inactivated viruses are added inside these vaccines as adjuvants. These inactivated viruses lose their ability to cause any disease.

Key Players

Key players operating in the pediatric drugs and vaccines market are-

• Abbott Laboratories (US)
• Baxter International Inc. (US)
• Boston Scientific Corporation (US)
• Becton
• Dickinson and Company (US)
• General Electric Company (GE Healthcare) (US)
• Johnson & Johnson (US)
• Masimo Corporation (US)
• Medtronic Care Management Services LLC (US)
• Omron Corporation (Japan).

Market Dynamics

The growing pediatric population worldwide is likely to spur the demand for pediatric drugs and vaccines which will, in turn, promote significant growth. In 2016, as per the U.S.-based non-profit organization Child Trends, there were nearly 78 million children below the age of 18, holding for 23.0% of the total U.S. population. Moreover, the growing number of births across the globe coupled with the growing prevalence of pediatric diseases are some of the factors stimulating global pediatric drugs and vaccine growth.

COVID-19 Impact

The COVID-19 outbreak impacted the growth of the pediatric drugs and vaccines market positively as the visits to hospitals for medical consultation decreased due to fear of getting infected. The usage of pediatric drugs and vaccines made it easier for the patients to be able to consult the healthcare providers online

Segments' Analysis

Disease Trends

The market has been divided into infectious disease, cancer, allergy & respiratory, nervous system disorders, cardiovascular disease, diabetes, and others. The infectious diseases segment accounted for a substantial market share in 2020. Growing global awareness about immunization against several infectious diseases that cause mortality and morbidity. An increase in the incidence of diseases, such as typhoid, chickenpox, measles, cholera, and hepatitis, in children, results in high demand for immunization, is likely to segment growth.

Regional Analysis

The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. A large children pool and growing treatment options for pediatric diseases are boosting the regional market growth. A well-established healthcare system and high per capita healthcare expenditure are further augmenting the growth of the pediatric drugs and vaccines market in the region.

To get the full scope of the report, Register Here

Target Audience

Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert-

• Distributors
• Suppliers
• Manufacturers
• Logistics organizations
• Government bodies

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What deliverables will you get in this report?

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.